As of close of business last night, Lilly(Eli) & Co’s stock clocked out at $734.37, down -3.64% from its previous closing price of $762.14. In other words, the price has decreased by -$27.77 from its previous closing price. On the day, 3964806 shares were traded. LLY stock price reached its highest trading level at $756.80 during the session, while it also had its lowest trading level at $727.62.
Ratios:
To gain a deeper understanding of LLY’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 238.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 880.47. For the most recent quarter (mrq), Quick Ratio is recorded 0.73 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 2.34 whereas as Long-Term Debt/Eq ratio is at 1.70.
On February 16, 2024, Morgan Stanley reiterated its Overweight rating and also lowered its target price recommendation from $805 to $950.
Daiwa Securities Downgraded its Buy to Outperform on December 21, 2023, whereas the target price for the stock was revised from $660 to $610.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 11 ’24 when Zakrowski Donald A sold 750 shares for $753.60 per share. The transaction valued at 565,200 led to the insider holds 7,880 shares of the business.
LILLY ENDOWMENT INC sold 169,684 shares of LLY for $132,521,930 on Feb 16 ’24. The 10% Owner now owns 98,898,810 shares after completing the transaction at $780.99 per share. On Feb 15 ’24, another insider, LILLY ENDOWMENT INC, who serves as the 10% Owner of the company, sold 50,316 shares for $760.46 each. As a result, the insider received 38,263,417 and left with 99,068,494 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LLY now has a Market Capitalization of 724.16B and an Enterprise Value of 746.46B. As of this moment, Lilly(Eli)’s Price-to-Earnings (P/E) ratio for their current fiscal year is 129.18, and their Forward P/E ratio for the next fiscal year is 40.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.45 while its Price-to-Book (P/B) ratio in mrq is 64.72. Its current Enterprise Value per Revenue stands at 21.87 whereas that against EBITDA is 87.12.
Stock Price History:
Over the past 52 weeks, LLY has reached a high of $800.78, while it has fallen to a 52-week low of $312.31. The 50-Day Moving Average of the stock is 691.89, while the 200-Day Moving Average is calculated to be 571.34.
Shares Statistics:
It appears that LLY traded 3.32M shares on average per day over the past three months and 3.51M shares per day over the past ten days. A total of 949.38M shares are outstanding, with a floating share count of 849.20M. Insiders hold about 10.63% of the company’s shares, while institutions hold 73.58% stake in the company. Shares short for LLY as of Feb 15, 2024 were 5.15M with a Short Ratio of 1.55, compared to 4.89M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.54% and a Short% of Float of 0.65%.
Dividends & Splits
With its trailing 12-month dividend rate of 4.52, LLY has a forward annual dividend rate of 4.69. Against a Trailing Annual Dividend Yield of 0.59%, it implies a Forward Annual Dividend Yield of 0.71%. The stock’s 5-year Average Dividend Yield is 1.47. The current Payout Ratio is 77.91% for LLY, which recently paid a dividend on Mar 08, 2024 with an ex-dividend date of Feb 14, 2024. Stock splits for the company last occurred on Oct 16, 1997 when the company split stock in a 2:1 ratio.
Earnings Estimates
As of right now, 14 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $2.52 for the current quarter, with a high estimate of $3.07 and a low estimate of $2.04, while EPS last year was $1.62. The consensus estimate for the next quarter is $2.77, with high estimates of $3.04 and low estimates of $2.51.
Analysts are recommending an EPS of between $13.26 and $11.86 for the fiscal current year, implying an average EPS of $12.52. EPS for the following year is $18.22, with 24 analysts recommending between $22.66 and $14.65.
Revenue Estimates
In the current quarter, 12 analysts expect revenue to total $8.99B. It ranges from a high estimate of $9.7B to a low estimate of $8.42B. As of the current estimate, Lilly(Eli) & Co’s year-ago sales were $6.96B, an estimated increase of 29.10% from the year-ago figure. For the next quarter, 12 analysts are estimating revenue of $9.91B, an increase of 19.20% less than the figure of $29.10% in the same quarter last year. There is a high estimate of $10.28B for the next quarter, whereas the lowest estimate is $9.56B.
A total of 24 analysts have provided revenue estimates for LLY’s current fiscal year. The highest revenue estimate was $43.91B, while the lowest revenue estimate was $40.4B, resulting in an average revenue estimate of $41.47B. In the same quarter a year ago, actual revenue was $34.12B, up 21.50% from the average estimate. Based on 24 analysts’ estimates, the company’s revenue will be $51.64B in the next fiscal year. The high estimate is $59.25B and the low estimate is $45.94B. The average revenue growth estimate for next year is up 24.50% from the average revenue estimate for this year.
